Cargando…
The tissue expression levels of SUMO1P 3 may be a reliable prognostic biomarker to predict the clinical outcomes in patients with HCC
Small ubiquitin-like modifier 1 pseudogene 3 (SUMO1P3) is a novel identified long non-coding RNA that is upregulated in several cancers and exerts its oncogenic effects via multiple pathways. SUMO1P3 was significantly higher in HCC tissues and cells than in non-cancerous specimens and normal cells....
Autores principales: | Yu, Henghai, Bai, Yitao, Xu, Chang, He, Xin, Liu, Qin, Ma, Dou, A, Yongjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668506/ https://www.ncbi.nlm.nih.gov/pubmed/33181633 http://dx.doi.org/10.1097/MD.0000000000021291 |
Ejemplares similares
-
Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of hepatocellular carcinoma (HCC)
por: Li, Mengting, et al.
Publicado: (2021) -
Elevated liver fibrosis index FIB-4 is not reliable for HCC risk stratification in predominantly non-Asian CHB patients
por: Demir, Münevver, et al.
Publicado: (2016) -
The outcome of the HCC patients underwent ALPPS: Retrospective study
por: Peng, Chihan, et al.
Publicado: (2019) -
KIF4A as a novel prognostic biomarker in cholangiocarcinoma
por: Zhang, Deng Yong, et al.
Publicado: (2021) -
Identification of prognostic miRNA biomarkers for esophageal cancer based on The Cancer Genome Atlas and Gene Expression Omnibus
por: Xue, Jinru, et al.
Publicado: (2021)